Jie Lu

Hybrid mesoporous silica nanoparticles with pH-operated and complementary H-bonding caps as an autonomous drug-delivery system.

Audrey Gallud, Jeffrey I Zink, J. Zink, 2014, Chemistry.

Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.

Zongxi Li, Monty Liong, Jeffrey I Zink, 2010, Small.

Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells.

Zongxi Li, Monty Liong, Jeffrey I Zink, 2010, Small.

Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery.

Monty Liong, Tian Xia, Andre E Nel, 2008, ACS nano.

Light-activated nanoimpeller-controlled drug release in cancer cells.

Jeffrey I Zink, J. Zink, F. Tamanoi, 2008, Small.

Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.

Courtney R. Thomas, Jeffrey I Zink, April D Pyle, 2013, Small.

Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.

Monty Liong, Jeffrey I Zink, J. Zink, 2007, Small.

Functional nanovalves on protein-coated nanoparticles for in vitro and in vivo controlled drug delivery.

Jeffrey I Zink, J. Zink, F. Tamanoi, 2015, Small.

Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells

Monty Liong, Tian Xia, Andre E Nel, 2007, Nanobiotechnology : the journal at the intersection of nanotechnology, molecular biology, and biomedical sciences.